The prospect of immunotherapy combined with chemotherapy in patients with advanced non-small cell lung cancer: a narrative review

OBJECTIVE: Based on a thorough analysis of monotherapy (pembrolizumab) and chemoimmunotherapy, the immunomodulatory effects of chemotherapy agents are emphasized. BACKGROUND: The combination of chemotherapy and immune checkpoint inhibitors should and is already being regarded as a new standard strat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ning, Xiangu, Yu, Yang, Shao, Songjun, Deng, Rong, Yu, Jie, Wang, Xuming, She, Xueke, Huang, Depei, Shen, Xudong, Duan, Weiming, Duan, Jin, Zhang, Hushan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667101/
https://www.ncbi.nlm.nih.gov/pubmed/34988212
http://dx.doi.org/10.21037/atm-21-4878

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667101/
https://www.ncbi.nlm.nih.gov/pubmed/34988212
http://dx.doi.org/10.21037/atm-21-4878

Ejemplares similares